Financhill
Back

Neurogene Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
14

NGNE
Neurogene

Last Price:
$22.69
Seasonality Move:
23.27%
Sell
35

NBY
NovaBay Pharmaceuticals

Last Price:
$0.54
Seasonality Move:
-0.66%
Sell
14
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $22.62. The Score for NGNE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.54. The Score for NBY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $22.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.24 Sell
Relative Strength Index (14 RSI): 40.31 Sell
Chaikin Money Flow: 33416 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.65 - 25.15) Buy
Bollinger Bands (100): (25.64 - 49.84) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 42.52 Sell
Chaikin Money Flow: 22882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.53 - 0.65) Sell
Bollinger Bands (100): (0.49 - 0.69) Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23 Sell
20-day SMA: 23.46 Sell
50-day SMA: 36.34 Sell
200-day SMA: 37.73 Sell
8-day EMA: 22.79 Sell
20-day EMA: 24.82 Sell
50-day EMA: 31.38 Sell
200-day EMA: 34.77 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.53 Buy
20-day SMA: 0.56 Sell
50-day SMA: 0.63 Sell
200-day SMA: 1.84 Sell
8-day EMA: 0.53 Buy
20-day EMA: 0.57 Sell
50-day EMA: 0.63 Sell
200-day EMA: 4.62 Sell

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):